TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
TCL Archive In Brief: Hammer Okay, Panel’s Pittsburgh Meeting Rescheduled For Oc 23; Campbell Leaves AICR July 17, 1987